Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Emily Cheng is a urologic surgeon and researcher whose work is transforming the surgical management of prostate cancer, with a focus on optimizing patient outcomes and healthcare efficiency. Her primary research areas include robotic-assisted radical prostatectomy (RARP), same-day discharge protocols, and comparative effectiveness of focal therapies. Dr. Cheng’s most impactful contribution is her pioneering study on same-day discharge versus inpatient RARP, which demonstrated that same-day discharge is safe, reduces costs, and maintains high patient satisfaction—a finding with 28 citations that has reshaped perioperative care, especially in the wake of the COVID-19 pandemic. She has also advanced the field by evaluating clipless techniques to reduce complications and by comparing partial gland cryoablation to robotic prostatectomy for cancer control, with 10 citations. Notably, her work on technical skill assessment of neurovascular bundle dissection links surgical precision to urinary continence recovery, offering actionable insights for improving postoperative quality of life. With a growing citation record exceeding 55 total citations, Dr. Cheng is recognized as an emerging leader in urologic oncology, driving evidence-based innovations that balance surgical excellence with patient-centered care.